Investigation of the Effects of Motor Imagery and Action Observation in People With Multiple Sclerosis
Launched by HACETTEPE UNIVERSITY · May 16, 2022
Trial Information
Current as of June 25, 2025
Completed
Keywords
ClinConnect Summary
This clinical trial is exploring the effects of two specific types of training—motor imagery and action observation training—on people with Multiple Sclerosis (MS). The goal is to see if these training methods, when added to standard rehabilitation, can improve important aspects like walking ability, fatigue levels, trunk control, and muscle oxygenation in individuals living with MS.
To join the study, participants need to be between 18 and 65 years old and have a confirmed diagnosis of MS. They should have a moderate disability level (measured by a standard scale) and must not have experienced an MS attack in the last three months. The study is looking for both men and women, and it is currently recruiting participants. Those who qualify can expect to engage in specific training sessions while receiving regular rehabilitation support, helping researchers understand how these new methods might enhance their recovery and daily functioning.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Being between the ages of 18-65
- • A definitive diagnosis of MS by a neurologist according to the 2017 McDonald Criteria
- • Expanded Disability Status Scale (EDSS) score of 4.0 and below (it is determined routinely by the physician during the examination)
- • Not having an attack in the last 3 months
- • A minimum score of 4 in each motor imagery ability (internal visual imagery, external visual imagery, and kinesthetic imagery) on the Movement Imagery Questionnaire-3 (MIQ-3)
- Exclusion Criteria:
- • cognitive impairment, defined as a Mini-Mental State Examination (MMSE) score of less than 24
- • Having another musculoskeletal, cardiovascular, pulmonary, metabolic, or neurological disease severe enough to preclude participation in the study.
- • Having severe vision and hearing problems
About Hacettepe University
Hacettepe University is a leading research institution in Turkey, renowned for its commitment to advancing medical science and healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, the university supports a wide range of clinical trials aimed at improving patient outcomes and developing new therapeutic approaches. Hacettepe University is dedicated to maintaining the highest ethical standards and regulatory compliance in its research endeavors, fostering an environment that promotes scientific excellence and contributes to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Trial Officials
Melike Sumeyye Ozen, M.Sc.
Principal Investigator
Bandırma Onyedi Eylül University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials